Atomistry » Magnesium » PDB 5v60-5voi » 5vof
Atomistry »
  Magnesium »
    PDB 5v60-5voi »
      5vof »

Magnesium in PDB 5vof: Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban

Enzymatic activity of Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban

All present enzymatic activity of Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban:
3.4.21.6;

Protein crystallography data

The structure of Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban, PDB code: 5vof was solved by S.Krishnaswamy, S.Kumar, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 37.05 / 2.25
Space group C 2 2 21
Cell size a, b, c (Å), α, β, γ (°) 55.744, 164.275, 124.521, 90.00, 90.00, 90.00
R / Rfree (%) 22 / 25.3

Other elements in 5vof:

The structure of Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban also contains other interesting chemical elements:

Fluorine (F) 19 atoms
Calcium (Ca) 1 atom
Chlorine (Cl) 1 atom
Sodium (Na) 1 atom

Magnesium Binding Sites:

The binding sites of Magnesium atom in the Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban (pdb code 5vof). This binding sites where shown within 5.0 Angstroms radius around Magnesium atom.
In total 2 binding sites of Magnesium where determined in the Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban, PDB code: 5vof:
Jump to Magnesium binding site number: 1; 2;

Magnesium binding site 1 out of 2 in 5vof

Go back to Magnesium Binding Sites List in 5vof
Magnesium binding site 1 out of 2 in the Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 1 of Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Mg101

b:43.2
occ:1.00
O1P A:CFL22 1.7 79.7 1.0
O A:HOH202 1.9 49.5 1.0
O A:HOH207 2.0 68.0 1.0
OP2 A:UFT23 2.2 92.2 1.0
O A:HOH203 2.2 45.0 1.0
OP1 A:A10 2.8 63.6 1.0
P A:CFL22 3.1 75.7 1.0
P A:UFT23 3.6 86.0 1.0
P A:A10 3.9 68.7 1.0
O2P A:CFL22 4.0 78.9 1.0
O5' A:CFL22 4.0 82.6 1.0
O3' A:A21 4.2 79.3 1.0
OP2 A:A10 4.2 64.2 1.0
C5' A:CFL22 4.3 85.9 1.0
O3' A:CFL22 4.3 89.4 1.0
C3' A:CFL22 4.3 89.0 1.0
O5' A:UFT23 4.5 84.8 1.0
O5' A:A10 4.6 68.3 1.0
O2P A:CFL9 4.6 76.4 1.0
OP1 A:UFT23 4.6 91.0 1.0
O3' A:CFL9 4.8 78.5 1.0
C5' A:A10 4.8 64.5 1.0
O6 A:G25 4.8 0.3 1.0
C5 A:UFT23 4.8 82.4 1.0
C4' A:CFL22 4.9 90.3 1.0

Magnesium binding site 2 out of 2 in 5vof

Go back to Magnesium Binding Sites List in 5vof
Magnesium binding site 2 out of 2 in the Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban


Mono view


Stereo pair view

A full contact list of Magnesium with other atoms in the Mg binding site number 2 of Desgla-XAS195A Bound to Aptamer 11F7T and Rivaroxaban within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Mg102

b:50.5
occ:1.00
OP2 A:A10 1.5 64.2 1.0
O A:HOH212 1.9 45.2 1.0
O A:HOH208 2.4 42.4 1.0
O4 A:UFT24 2.4 74.5 1.0
P A:A10 2.7 68.7 1.0
O5' A:A10 3.2 68.3 1.0
N1 A:G25 3.6 92.4 1.0
C4 A:UFT24 3.6 78.8 1.0
N2 A:G25 3.7 0.6 1.0
F A:CFL9 3.9 93.0 1.0
O4 A:UFT23 3.9 82.0 1.0
O3' A:CFL9 4.0 78.5 1.0
OP1 A:A10 4.0 63.6 1.0
O A:HOH203 4.0 45.0 1.0
C2 A:G25 4.1 95.5 1.0
N3 A:UFT24 4.4 79.1 1.0
OP2 A:G11 4.5 69.2 1.0
C3' A:CFL9 4.5 74.9 1.0
C6 A:G25 4.5 84.5 1.0
C5 A:UFT24 4.6 79.4 1.0
C5' A:A10 4.6 64.5 1.0
O A:HOH207 4.6 68.0 1.0
O6 A:G25 4.6 0.3 1.0
O6 A:G13 4.7 71.5 1.0
C2' A:CFL9 4.7 70.9 1.0
C4 A:UFT23 4.8 83.1 1.0
C5 A:UFT23 5.0 82.4 1.0

Reference:

R.Gunaratne, S.Kumar, J.W.Frederiksen, S.Stayrook, J.L.Lohrmann, K.Perry, K.M.Bompiani, C.V.Chabata, N.K.Thalji, M.D.Ho, G.Arepally, R.M.Camire, S.Krishnaswamy, B.A.Sullenger. Combination of Aptamer and Drug For Reversible Anticoagulation in Cardiopulmonary Bypass. Nat. Biotechnol. V. 36 606 2018.
ISSN: ISSN 1546-1696
PubMed: 29863725
DOI: 10.1038/NBT.4153
Page generated: Mon Sep 30 06:11:50 2024

Last articles

Zn in 9JPJ
Zn in 9JP7
Zn in 9JPK
Zn in 9JPL
Zn in 9GN6
Zn in 9GN7
Zn in 9GKU
Zn in 9GKW
Zn in 9GKX
Zn in 9GL0
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy